Dioseve Inc.
PrivateLast Round
Series A
Extension
Jun 16, 2026
Total Funding Raised
$17M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Dioseve Inc. is a biotechnology company that develops assisted reproductive technology using oocytes and ovarian somatic cells derived from induced pluripotent stem (iPS) cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dioseve Inc. Comparables
Compare Dioseve Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conception | 87% | |
| Ivy Natal | 86% | |
| Vitra Labs | 84% | |
Dioseve Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 16, 2026 | ||||
| Series A | Jun 27, 2024 | ||||
| Seed | Aug 18, 2022 |
Dioseve Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coral Capital | Seed |
| Shionogi & Co. | Series A Extension |
| D4V (Design for Ventures) | Series A Extension |
| Hokuriku Region Venture Fund | Series A |
| DG Daiwa Ventures | Series A Extension, Series A |
| ANRI株式会社 | Series A, Seed |
| Miraidoa | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Led by Shionogi & Co.
- Apr 1, 2026
Assisted reproductive technology using iPS cells has entered the clinical research phase.
Dioseve Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dioseve Inc.'s valuation, stock price, and market status.